ETON

Eton Pharmaceuticals (ETON)

Eton Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ETON

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/20	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/12/20	20 : 50	GlobeNewswire Inc.	Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/12/17	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/12/17	20 : 50	GlobeNewswire Inc.	Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/12/13	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/12/13	06 : 27	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/12/10	07 : 11	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/12/03	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/12/03	20 : 50	GlobeNewswire Inc.	Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/11/25	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/11/25	20 : 50	GlobeNewswire Inc.	Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/11/13	06 : 25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/11/13	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/11/13	06 : 01	GlobeNewswire Inc.	Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/11/07	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/11/07	21 : 00	GlobeNewswire Inc.	Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/11/07	06 : 30	GlobeNewswire Inc.	Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/10/05	05 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/10/03	19 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/10/03	19 : 30	GlobeNewswire Inc.	Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/08/23	05 : 30	GlobeNewswire Inc.	Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/08/09	05 : 25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/08/09	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/08/09	05 : 01	GlobeNewswire Inc.	Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/08/03	05 : 16	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/07/31	06 : 30	GlobeNewswire Inc.	Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/07/16	05 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/07/16	05 : 05	GlobeNewswire Inc.	Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/06/12	05 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ETON	Eton Pharmaceuticals Inc
2024/05/10	05 : 25	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ETON	Eton Pharmaceuticals Inc